Neurolens

Coppell, United States

Neurolens designs prescription lenses that add a contoured prism to bring the eyes into alignment.

$45.0M raised

Dec 2023

Venture - Series Unknown

Top Investors

MVM Life Science PartnersMarshall WaceBluestem CapitalFalcon VisionTrinary Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neurolens raised?

Neurolens has raised $45.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.

Who are Neurolens's investors?

Neurolens's investors include MVM Life Science Partners, Marshall Wace, Bluestem Capital, Falcon Vision, Trinary Capital.

Where is Neurolens headquartered?

Neurolens is headquartered in Coppell, United States.

What does Neurolens do?

Neurolens designs prescription lenses that add a contoured prism to bring the eyes into alignment.

What stage is Neurolens at?

Neurolens is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 5, 2023.

MLA

"Neurolens — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/neurolens. Accessed June 21, 2026.

APA

VCBacked. (2023). Neurolens — Funding & Investors. Retrieved June 21, 2026, from https://www.vcbacked.co/company/neurolens

Wikipedia (cite web)

{{cite web |title=Neurolens — Funding & Investors |url=https://www.vcbacked.co/company/neurolens |website=VCBacked |access-date=June 21, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 5, 2023.